HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Blair, M. Articles by Quigley, H. Search for Related Content PubMed PubMed Citation Articles by Blair, M. Articles by Quigley, H.

Effect of Glatiramer Acetate on Primary and Secondary Degeneration of Retinal Ganglion Cells in the Rat

From the Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, Maryland.

PURPOSE. After crush injury to the optic nerve, elevated intraocular pressure, and glutamate toxicity, the immune modulator glatiramer acetate (GA, Cop-1; Copaxone; Teva Pharmaceutical Industries, Pitach Tikva, Israel) has been shown to reduce the delayed cell death of retinal ganglion cells (RGCs). This study was undertaken to confirm the protective effect of GA on secondary degeneration of RGCs in the rat, by using a spatial, rather than temporal, model.

METHODS. A total of 131 Wistar rats divided into 10 groups underwent bilateral stereotactic injection of fluorescent tracer (Fluorogold; Fluorochrome, Denver, CO) into the superior colliculus to label RGCs. They received a concurrent subcutaneously injection of (1) GA mixed with complete Freund’s adjuvant (CFA), (2) CFA alone, or (3) saline. One week later, the superior one third of the left optic nerve was transected in animals in the six partial transection groups. Optic nerves in four additional groups underwent full transection. Rats were killed and retinas harvested from both eyes 1 or 4 weeks after partial transection and 1 or 2 weeks after full transection. RGC densities were calculated from retinal wholemounts, and differences between right (control) and left (transected) eyes were compared across treatment groups.

RESULTS. Among the partial transection groups, differences in the mean percentage of RGC loss in the inferior retinas were not significant at 1 or 4 weeks (ANOVA; P = 0.20, P = 0.12, respectively). After full transection, there was significantly more RGC loss in the GA group than in the CFA group when comparing whole retinas at 1 week, but not at 2 weeks (two-tailed t-test; P = 0.04, P = 0.36, respectively).

CONCLUSIONS. There is no evidence that GA has a neuroprotective effect after optic nerve transection, either for primarily injured or secondarily involved RGC.

This article has been cited by other articles:

				Y. Munemasa, S. H. Kim, J. H. Ahn, J. M. K. Kwong, J. Caprioli, and N. Piri Protective Effect of Thioredoxins 1 and 2 in Retinal Ganglion Cells after Optic Nerve Transection and Oxidative Stress Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3535 - 3543. [Abstract] [Full Text] [PDF]

				Z. Yang, H. A. Quigley, M. E. Pease, Y. Yang, J. Qian, D. Valenta, and D. J. Zack Changes in Gene Expression in Experimental Glaucoma and Optic Nerve Transection: The Equilibrium between Protective and Detrimental Mechanisms Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5539 - 5548. [Abstract] [Full Text] [PDF]

				W. Huang, J. B. Fileta, A. Dobberfuhl, T. Filippopolous, Y. Guo, G. Kwon, and C. L. Grosskreutz Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma PNAS, August 23, 2005; 102(34): 12242 - 12247. [Abstract] [Full Text] [PDF]